Tb Screening Updates: New Diagnostics and Why Testing Protocol Is Changing
By Sophia Al-Mansoor
No universal millimeter cutoff defines a positive reaction across all patients. To balance test sensitivity against unnecessary treatment, public health agencies apply a three-tiered risk framework based on individual immune function and epidemiological vulnerability.
A measurement of 5 mm or greater is positive for individuals at the highest risk of rapid progression to active disease. This group includes people living with HIV, organ transplant recipients, individuals taking immunosuppressive therapies (such as tumor necrosis factor-alpha inhibitors or systemic corticosteroids equivalent to 15 mg daily of prednisone for a month), and contacts who had direct, sustained exposure to someone with infectious tuberculosis.
A measurement of 10 mm or greater qualifies as positive for individuals with clinical conditions or occupational profiles that increase risk. This threshold captures recent immigrants from high-burden regions (arriving within five years), healthcare workers, personnel in correctional facilities or homeless shelters, mycobacteriology laboratory staff, children under four years old, and patients managing diabetes, silicosis, or chronic renal failure.
For individuals with no known risk factors for tuberculosis, the threshold rises to 15 mm or greater. This high baseline minimizes false positives in populations where baseline prevalence is low.
Sophia analyzes international trade, startup ecosystems, retail transformation, and supply chain logistics for modern digital publications.
